Trials Sponsors Conditions Drugs Pricing

Conditions

Preterm Children

Outcome Measures

Primary Outcomes (1)

Insulin resistance as measured by the Triglyceride-Glucose Index
1 day

Secondary Outcomes (5)

Insulin resistance as measured by the Homeostasis Model Assessment - Insulin Resistance index
1 day
Body composition (percentage of fat versus fat free mass) by BOP-POD and by impedancemetry (biodyXpert) for assessment of body composition variations between peripubertal period and neonatal period
1 day
creatinine clearance
1 day
Eating behaviour using standardized questionnaire named Child Eating Behaviour questionnaire
1 day
Eating behaviour using standardized french questionnaire named "QCAJE Questionnaire Comportement Alimentaire du Jeune Enfant"
1 day

Study Arms (1)

Children born prematurely included in the EPIPOD protocol and now in the peripubertal period

EXPERIMENTAL

At inclusion in the INFANTPOD study : * Blood and urinary samples collection for evaluation of insulin resistance and of renal function analysis. * Assessment of body composition by a commercialized device called "BOP-POD" and by impedancemetry * Assessment of pulse wave by a commercialized device called "popmetre" * Questionnaires for analysis of eating behaviour * Assessment of physical activity by a commercialized device called "accelerometer" and by questionnaire.

Other: clinical and biological measurements and questionnaires

Interventions

clinical and biological measurements and questionnairesOther

Blood and urinary samples collection for evaluation of insulin resistance and of renal function analysis. Assessment of body composition by BOP-POD and by impedancemetry. Assessment of pulse wave by popmetre. Assessment of physical activity by accelerometer and by questionnaire Questionnaires for analysis of eating behaviour

Children born prematurely included in the EPIPOD protocol and now in the peripubertal period

Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.

Eligibility Criteria

Age8 Years - 14 Years

Sexall

Healthy VolunteersNo

Age GroupsChild (0-17)

You may qualify if:

Children hospitalised at the Nantes University Hospital in the neonatal period
With a body composition measurement performed at discharge from neonatal hospitalization as part of the EPIPOD protocol

Sponsors & Collaborators

Nantes University Hospital
Otherlead

Study Sites (1)

Nantes University Hospital

Nantes, 44600, France

RECRUITING

Anne FRONDAS, DoctorCONTACT+33 2 40 08 34 83 anne.frondas@chu-nantes.fr

MeSH Terms

Interventions

Surveys and Questionnaires

Intervention Hierarchy (Ancestors)

Data CollectionEpidemiologic MethodsInvestigative TechniquesHealth Care Evaluation MechanismsQuality of Health CareHealth Care Quality, Access, and EvaluationPublic HealthEnvironment and Public Health

Central Study Contacts

Anne FRONDAS, Doctor

CONTACT

+33 2 40 08 34 83 anne.frondas@chu-nantes.fr

Study Design

Study Type: interventional
Phase: not applicable
Allocation: NA
Masking: NONE
Purpose: BASIC SCIENCE
Intervention Model: SINGLE GROUP
Sponsor Type: OTHER
Responsible Party: SPONSOR

Study Record Dates

First Submitted

June 15, 2021

First Posted

June 30, 2021

Study Start

February 2, 2022

Actual (reported)

Primary Completion

February 2, 2028

Estimated

Planned date reported by the registry; this milestone is not confirmed as achieved.

Follow-up During the Peripubertal Period of Preterm Children Included in the Protocol Entitled "EPIPOD".

Brief Summary

Registry Overview

Trial Relationships

Study Timeline

First Submitted

First Posted

Study Start

Primary Completion

Study Completion

Conditions

Outcome Measures

Primary Outcomes (1)

Secondary Outcomes (5)

Study Arms (1)

Children born prematurely included in the EPIPOD protocol and now in the peripubertal period

Interventions

Eligibility Criteria

You may qualify if:

Sponsors & Collaborators

Study Sites (1)

MeSH Terms

Interventions

Intervention Hierarchy (Ancestors)

Central Study Contacts

Study Design

Study Record Dates

You may not qualify if:

Source record

Locations

Brief Summary

Registry Overview

Trial Relationships

Related Scientific Literature

Study Timeline

First Submitted

First Posted

Study Start

Primary Completion

Study Completion

Conditions

Outcome Measures

Primary Outcomes (1)

Secondary Outcomes (5)

Study Arms (1)

Children born prematurely included in the EPIPOD protocol and now in the peripubertal period

Interventions

Eligibility Criteria

You may qualify if:

Sponsors & Collaborators

Study Sites (1)

MeSH Terms

Interventions

Intervention Hierarchy (Ancestors)

Central Study Contacts

Study Design

Study Record Dates

You may not qualify if:

Source record

Locations